Nalaganje...
Clinical Pharmacokinetics and Pharmacodynamics of Nintedanib
Nintedanib is an oral, small-molecule tyrosine kinase inhibitor approved for the treatment of idiopathic pulmonary fibrosis and patients with advanced non-small cell cancer of adenocarcinoma tumour histology. Nintedanib competitively binds to the kinase domains of vascular endothelial growth factor...
Shranjeno v:
| izdano v: | Clin Pharmacokinet |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer International Publishing
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6719436/ https://ncbi.nlm.nih.gov/pubmed/31016670 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-019-00766-0 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|